Fractional Exhaled Nitric Oxide as an Inflammatory Biomarker in Chronic Obstructive Pulmonary Disease (COPD) with or without Concurrent Diagnosis of Asthma: The Canadian Cohort Obstructive Lung Disease (CanCOLD)

Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi,Nafiseh Naderi,Palmina Mancino,Pei Zhi Li,Wan Tan,Jean Bourbeau

DOI: https://doi.org/10.1080/15412555.2020.1779681

2020-06-25

Abstract:We studied whether fractional exhaled nitric oxide (<i>F</i>_ENO) can differentiate chronic obstructive pulmonary disease (COPD) with concurrent diagnosis of asthma from COPD-only as well as its ability to predict disease severity and progression.This study was embedded in the Canadian Cohort Obstructive Lung Disease (CanCOLD). Subjects of ≥40 years old completed <i>F</i>_ENO measurements were subdivided into four groups, including COPD (<i>N</i> = 86 [COPD-only (<i>N</i> = 35) and COPD with concurrent diagnosis of asthma (<i>N</i> = 51)], healthy (<i>N</i> = 72), and at risk (<i>N</i> = 151). Three of the most common clinical definitions were used for characterizing COPD with concurrent diagnosis of asthma: 1) atopy and self-reported physician diagnosis of asthma, 2) ≥12% and ≥200 ml post-bronchodilator FEV1; 3) self-reported physician diagnosis of asthma. <i>F</i>_ENO values were classified using quartiles and the American Thoracic Society (ATS) guideline 2011.Compared to COPD-only, more COPD with concurrent diagnosis of asthma had a significant <i>F</i>_ENO50 level of <span class="NLM_disp-formula inline-formula"><math>≥</math></span> 33.5 ppb (fourth quartile) than COPD-only (<i>p</i> = 0.045, 0.011, and 0.006, for definition 1, 2, and 3, respectively). Considering the ATS guideline 2011, fewer COPD with concurrent diagnosis of asthma had <i>F</i>_ENO50 &lt; 25 than COPD-only, which was statistically significant with definition 1 and 3 (<i>p</i> = 0.038 and 0.026, respectively).<i>F</i>_ENO as a biomarker has the potential to be used as a complementary value for differentiating COPD with concurrent diagnosis of asthma from COPD-only. Further studies should be conducted on validated definitions of COPD with concurrent diagnosis of asthma, which may include a reference to the type of airway inflammation in addition to the clinical definition.